LHC Group (LHCG) Receives Hold Rating from Robert W. Baird

Robert W. Baird reiterated their hold rating on shares of LHC Group (NASDAQ:LHCG) in a report released on Tuesday morning. The brokerage currently has a $63.00 price target on the health services provider’s stock.

LHCG has been the subject of a number of other reports. Royal Bank Of Canada restated a buy rating and set a $69.00 price objective on shares of LHC Group in a research report on Tuesday, July 18th. Benchmark Co. raised their price objective on LHC Group from $63.00 to $72.00 and gave the stock a buy rating in a research report on Thursday, June 8th. Jefferies Group LLC reaffirmed a buy rating and set a $65.00 price target on shares of LHC Group in a research note on Friday, June 9th. BidaskClub downgraded LHC Group from a strong-buy rating to a buy rating in a research note on Wednesday, July 12th. Finally, Zacks Investment Research raised LHC Group from a hold rating to a buy rating and set a $67.00 price target for the company in a research note on Saturday, August 5th. One research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average price target of $66.60.

LHC Group (NASDAQ:LHCG) opened at 65.15 on Tuesday. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35. The firm has a market cap of $1.19 billion, a P/E ratio of 28.83 and a beta of 0.76. The stock’s 50 day moving average is $63.01 and its 200-day moving average is $59.34.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The firm had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. During the same period last year, the company posted $0.52 EPS. The business’s quarterly revenue was up 15.1% compared to the same quarter last year. Analysts forecast that LHC Group will post $2.39 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “LHC Group (LHCG) Receives Hold Rating from Robert W. Baird” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2017/09/13/lhc-group-lhcg-receives-hold-rating-from-robert-w-baird.html.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Coliseum Capital Management, L sold 14,450 shares of the firm’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $65.69, for a total value of $949,220.50. The disclosure for this sale can be found here. 14.80% of the stock is owned by company insiders.

Hedge funds have recently modified their holdings of the stock. Swiss National Bank raised its stake in shares of LHC Group by 2.8% in the 1st quarter. Swiss National Bank now owns 25,535 shares of the health services provider’s stock valued at $1,376,000 after acquiring an additional 700 shares in the last quarter. Legal & General Group Plc raised its stake in shares of LHC Group by 1.2% in the 1st quarter. Legal & General Group Plc now owns 25,087 shares of the health services provider’s stock valued at $1,353,000 after acquiring an additional 290 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of LHC Group by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock valued at $77,185,000 after acquiring an additional 54,279 shares in the last quarter. Iguana Healthcare Management LLC raised its stake in shares of LHC Group by 16.7% in the 1st quarter. Iguana Healthcare Management LLC now owns 35,000 shares of the health services provider’s stock valued at $1,887,000 after acquiring an additional 5,000 shares in the last quarter. Finally, Point72 Asset Management L.P. raised its stake in shares of LHC Group by 292.3% in the 1st quarter. Point72 Asset Management L.P. now owns 439,399 shares of the health services provider’s stock valued at $23,684,000 after acquiring an additional 327,399 shares in the last quarter. 85.93% of the stock is currently owned by institutional investors and hedge funds.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply